A postmarketing study investigating the effect of natalizumab in French patients with multiple sclerosis

Trial Profile

A postmarketing study investigating the effect of natalizumab in French patients with multiple sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Natalizumab (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BIONAT
  • Most Recent Events

    • 27 Jun 2017 Results evaluating the relation between immunoglobulin levels and JC virus serology on multiple sclerosis patients, presented at the 3rd Congress of the European Academy of Neurology.
    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top